New tissue microarray technology for analyses of gene expression in frozen pathological samples

BioTechniques

Volumn 43, Issue 1, 2007, Pages 101-105

  Zhou, Lei ^a   Hodeib, Melissa ^b   Abad, Joseph D ^b   Mendoza, Leopoldo ^a   Kore, Anilkumar R ^a   Hu, Zhongting ^b  

^a APPLIED BIOSYSTEMS   (United States)

^b WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FROZEN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOLOGICAL TISSUES; TISSUE MICROARRAYS (TMA);

MICROARRAYS; PARAFFINS; PROTEINS; RNA; TISSUE;

GENE EXPRESSION;

DNA; PARAFFIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FROZEN SECTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICROTOME; MOUSE; NONHUMAN; QUALITY CONTROL; RNA ANALYSIS;

ANIMALS; CRYOPRESERVATION; DISEASE; GENE EXPRESSION PROFILING; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (PHOSPHORYLATING); HUMANS; MICE; RNA, MESSENGER; TISSUE ARRAY ANALYSIS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 34447643408     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/000112498     Document Type: Article

References (24)

1. Hsu, F.D., T.O. Nielsen, A. Alkushi, B. Dupuis, D. Huntsman, C.L. Liu, M. van de Rijn, and C.B. Gilks. 2002. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry. Mod. Pathol. 15:1374-1380.
2. Hofmann, H.S., G. Hansen, G. Richter, C. Taege, A. Simm, R.E. Silber, and S. Burdach. 2005. Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients. Clin. Cancer Res. 11:1086-1092.
3. Yu, Z., P.M. Weinberger, B.G. Haffty, C. Sasaki, C. Zerillo, J. Joe, D. Kowalski, J. Dziura, et al. 2005. Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma. Clin. Cancer Res. 11:1160-1166.
4. Bowen, C., L. Bubendorf, H.J. Voeller, R. Slack, N. Willi, G. Sauter, T.C. Gasser, P. Koivisto, et al. 2000. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Res. 60:6111-6115.
5. Andersen, C.L., O. Monni, U. Wagner, J. Kononen, M. Barlund, C. Bucher, P. Haas, A. Nocito, et al. 2002. High-throughput copy number analysis of 17q23 in 3520 tissue specimens by fluorescence in situ hybridization to tissue microarrays. Am. J. Pathol. 161:73-79.
6. Varambally, S., S.M. Dhanasekaran, T.R. Barrette, M.G. Sanda, D. Ghosh, K.J. Pienta, R.G. Sewalt, A.P. Otte, et al. 2002. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419:624-629.
7. Kay, E., A. O'Grady, J.M. Morgan, S. Wozniak, and B. Jasani. 2004. Use of tissue microarray for interlaboratory validation of HER2 immunocytochemical and FISH testing. J. Clin. Pathol. 57:1140-1144.
8. Bubendorf, L., M. Kolmer, J. Kononen, P. Koivisto, S. Mousses, Y. Chen, E. Mahlamaki, P. Schraml, et al. 1999. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J. Natl. Cancer Inst. 91:1758-1764.
9. Mousses, S., A. Kallioniemi, A. Elkahloun, and O.P. Kallioniemi. 2002. Clinical and functional target validation using tissue and cell microarrays. Curr. Opin. Chem. Biol. 6:97-101.
10. Kononen, J., L. Bubendorf, A. Kallioniemi, M. Barlund, P. Schraml, S. Leighton, J. Torhorst, M.J. Mihatsch, et al. 1998. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4:844-847.
11. Scicchitano, M.S., D.A. Dalmas, M.A. Bertiaux, S.M. Anderson, L.R. Turner, R.A. Thomas, R. Mirable, and R.W. Boyce. 2006. Preliminary comparison of quantity, quality, and microarray performance of RNA extracted from formalin-fixed, paraffin-embedded, and unfixed frozen tissue samples. J. Histochem. Cytochem. 54:1229-1237.
12. Hoos, A. and C. Cordon-Cardo. 2001. Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab. Invest. 81:1331-1338.
13. Schoenberg, F.M. and D.J. Slamon. 2001. Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins. Am. J. Pathol. 159:1645-1650.
14. Shergill, I.S., N.K. Shergill, M. Arya, and H.R.H. Patel. 2004. Tissue microarrays: a current medical research tool. Curr. Med. Res. Opin. 20:707-712.
15. Simon, R., M. Mirlacher, and G. Saulter. 2004. Tissue microarrays. BioTechniques 36:98-105.
16. Waschek, J.A., R.A. Casillas, T.B. Nguyen, E.M. DiCicco-Bloom, E.M. Carpenter, and W.I. Rodriguez. 1998. Neural tube expression of pituitary adenylate cyclase-activating peptide (PACAP) and receptor: potential role in patterning and neurogenesis. Proc. Natl. Acad. Sci. USA 95:9602-9607.
17. Camp, R.L., L.A. Charette, and D.L. Rimm. 2000. Validation of tissue microarray technology in breast carcinoma. Lab. Invest. 80:1943-1949.
18. Hoos, A., M.J. Urist, A. Stojadinovic, S. Mastorides, M.E. Dudas, D.H. Leung, D. Kuo, M.F. Brennan, et al. 2001. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am. J. Pathol. 158:1245-1251.
19. Fernebro, E., M. Dictor, P.O. Bendahl, M. Ferno, and M. Nilbert. 2002. Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer. Arch. Pathol. Lab. Med. 126:702-705.
20. Baldino, F., Jr., S. Fitzpatrick-McElligott, I. Gozes, and J.P. Card. 1989. Localization of VIP and PHI-27 messenger RNA in rat thalamic and cortical neurons. J. Mol. Neurosci. 1:199-207.
21. Ratcliffe, E.M., D.J. deSa, M.F. Dixon, and R.H. Stead. 1998. Choline acetyltransferase (ChAT) immunoreactivity in paraffin sections of normal and diseased intestines. J. Histochem. Cytochem. 46:1223-1231.
22. Chen, Y., M. Sato, C. Endo, A. Sakurada, H. Aikawa, H. Takahashi, T. Tanita, T. Kondo, et al. 1999. Expression of Bcl-2, Bax, and p53 proteins in carcinogenesis of squamous cell lung cancer. Anticancer Res. 19:1351-1356.
23. Stopyra, G.A., M.J. Warhol, and H.A. Multhaupt. 2001. Utility of CK7 and CK20 mmunohistochemistry in the detection of synchronous breast and colon carcinoma in a pleural effusion: a case report and supporting survey of archival material. Diagn. Cytopathol. 25:54-58.
24. Jassem, J., E. Jassem, J. Jakobkiewicz-Banecka, W. Rzyman, A. Badzio, R. Dziadziuszko, G. Kobierska-Guilida, A. Szymanowska, et al. 2004. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with non-small cell lung carcinoma. Cancer 100:1951-1960.